A Multiple Dose Pharmacokinetic Study of Perampanel in Korean Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 11 Mar 2015
At a glance
- Drugs Perampanel (Primary)
- Indications Partial epilepsies
- Focus Pharmacokinetics
- Sponsors Eisai Co Ltd
- 19 Sep 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 28 Feb 2014 According to ClinicalTrials.gov record, planned end date changed from 1 Apr 2015 to 1 Apr 2014.
- 20 Jan 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.